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Abstract
Ring opening of phthalic anhydride has been carried out in acetic acid with glycine, b-alanine, L-phenylalanine,
and 4-aminobenzoic acid to yield, respectively, 2-{[(carboxymethyl)amino]carbonyl}benzoic acid (I), 2-{[(2-
carboxyethyl)amino]carbonyl}benzoic acid (II), 2-{[(1-carboxy-2-phenylethyl)amino]carbonyl}benzoic acid (III), and 2-
[(4-carboxyanilino)carbonyl]benzoic acid (IV). Compounds I-IV have been employed as ligands for Sb(III) center
(complexes V-VIII) in aqueous medium. FTIR and
1H NMR spectra proved the deprotonation of carboxylic protons
and coordination of imine group and thereby tridentate behaviour of the ligands as chelates. Elemental, MS, and
TGA analytic data confirmed the structural hypothesis based on spectroscopic results. All the compounds have
been assayed in vitro for anti-leishmanial and anti-fungal activities against five leishmanial strains L. major (JISH118),
L. major (MHOM/PK/88/DESTO), L. tropica (K27), L. infantum (LEM3437), L. mex mex (LV4), and L. donovani (H43); and
Aspergillus Flavus, Aspergillus Fumigants, Aspergillus Niger, and Fusarium Solani. Compound VII exhibited good anti-
leishmanial as well as anti-fungal impacts comparable to reference drugs.
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Background
Trivalent antimony reagents are extensively consumed
in industrial processes, e.g., in catalysis for the synthesis
of polymers akin ethyleneterephthalate, with different
brand names like Dacron
® and Mylar
®. Similarly, anti-
mony alkoxides have also been employed as precursors
for the deposition of thin films of Sb2O3 and Sb6O13
[1-4]. The literature also revealed use of trivalent anti-
mony compounds in fluorine chemistry and their suit-
ability as solid electrolytes, piezoelectrics, and
ferroelectrics [5,6]. On the other hand, the use of tri-
and pentavalent antimony containing compounds as
drugs for the treatment of leishmaniasis span more than
50 years; but little is known about the actual mechan-
isms of antimony toxicity and drug resistance [7,8]. Car-
boxylic group-containing compounds are versatile
ligands to act as unidentate, bidentate, or bridging
ligands; moreover, these also act as a spacer between Sb
and other moieties [9-13]. All these facts prompted us
to investigate the chemistry as well and biocidal effects
of antimony
III complexes formed with ligands containing
two carboxylic groups.
Experimental
As received grade chemicals used during this study were
procured from Sigma; the solvents were dried as
reported [14]. C, H, and N analyses were carried out on
a Yanaco high-speed CHN analyzer; antipyrene was
used as a reference, while antimony was estimated
according to the reported procedure [15]; melting points
were recorded on Gallenkmp capillary melting point
apparatus and are uncorrected. FTIR spectra of all the
compounds were taken on Bruker FTIR spectrophot-
ometer TENSOR27 using OPUS software in the range
of 5000-400 cm
-1 (ZnSe).
1Ha n d
13CN M Rs p e c t r ai n
DMSO were recorded on a multinuclear Avance 300
and 75 MHz FT NMR spectrometer operating at room
temperature, i.e., 25 C. Thermoanalytical measurements
were carried out using a Perkin Elmer Thermogravi-
metric/differential thermal analyzer (YRIS Diamond TG-
DTA High Temp. Vacu.) consuming variable heating
rates between 0.5°C/min and 50°C/min. HR FAB-MS
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Licensespectra were obtained from a double-focusing mass
spectrometer Finnigan (MAT 112).
Synthesis of ligands
Phthalic anhydride (5 g, 33.77 mM) was dissolved in
acetic acid (100 mL), and a cold solution of amino acid
(33.77 mM, i.e. 2.53 g, 3 g, 5.58 g, and 4.63 g of glycine,
b-alanine, L-phenylalanine, and 4-aminobenzoic acid,
respectively) in acetic acid (75 mL) was added to it. This
mixture was stirred at room temperature for 3 hours
resulting in white precipitate. The white precipitate was
washed several times with cold water and recrystallized
from water.
Synthesis of I
Yield: 72%. C10H9NO5: Calcd. (%): C 53.82, H 4.06, and
N 6.28; Found (%): C 53.27, H 3.86, N 6.01; FAB-MS
(m/z) 224 (M + 1); IR ν 3293 (N-H), 1684 (C-N), 1592
(CO2)as, and 1353 (CO2)s, Δν (CO2): 239 cm
-1.
1HN M R
(DMSO-d6, 300 MHz) 12.8 (s, COOH), 12.1 (s, COOH),
8.31 (s, NH), 7.02-7.61 (Ar), and 3.62 (s, CH2).
13C
NMR (DMSO-d6, 75 MHz) 174.7 (COOH), 170.2
(CONH), 168.9 (COOH), 107-138 (Ar), and 44.6 (CH2).
Synthesis of II
Yield: 67%. C11H11NO5: Calcd. (%): C 55.70, H 4.67, N
5.90; Found (%): C 55.24, H 4.03, N 5.42. FAB-MS (m/z)
238 (M + 1). IR ν 3372 (N-H), 1670 (C-N), 1581 (CO2)
as, 1345 (CO2)s, Δν (CO2): 236 cm
-1.
1H NMR (DMSO-
d6, 300 MHz) 12.7 (s, COOH), 12.5 (s, COOH), 8.39 (s,
NH), 7.07-7.59, (m, Ar) 3.51 (t, CH2 J:3 . 4 2 ) ,2 . 3 3( t ,
CH2 J:4 . 1 ) .
13C NMR (DMSO-d6, 75 MHz) 173.2
(COOH), 168.8 (COOH), 142.4 (CONH), 109-140 (Ar),
40.4 (CH2), 35.2 (CH2).
Synthesis of III
Yield: 80%. C17H15NO5: Calcd. (%): C 65.17, H 4.83, N
4.47; Found (%): C 64.86, H 4.32, N 4.11. FAB-MS (m/z)
314 (M + 1). IR ν 3380 (N-H), 1686 (C-N), 1577 (CO2)
as, 1361 (CO2)s, Δν (CO2): 216 cm
-1.
1H NMR (DMSO-
d6, 300 MHz) 12.6 (s, COOH), 12.2 (s, COOH), 8.43 (s,
NH), 7.02-7.51 (m, Ar), 5.06 (q, CH, J:8 . 8 ) ,3 . 4( d ,C H 2,
J: 10.1).
13C NMR (DMSO-d6, 75 MHz) 171.4 (COOH),
170.0 (COOH), 144.1 (CONH), 111-138 (Ar), 61.2 (CH),
36.1 (CH2).
Synthesis of IV
Yield: 70%. C15H11NO5: Calcd. (%): C 63.16, H 3.89, N
4.91; Found (%): C 63.02, H 3.43, N 4.60. FAB-MS (m/z)
286 (M + 1). IR ν 3388 (N-H), 1672 (C-N), 1566 (CO2)as,
1371 (CO2)s, Δν (CO2): 195 cm
-1.
1H NMR (DMSO-d6,
300 MHz) 12.3 (s, COOH), 11.8 (s, COOH), 8.52 (s, NH),
7.13-8.33 (m, Ar).
13C NMR (DMSO-d6, 75 MHz) 176.7
(COOH), 165.4 (COOH), 148.2 (CONH), 120-136 (Ar).
Synthesis of antimony complexes
Aqueous solution of SbCl3 was made by dissolving 0.5 g
(2.19 mM) in 10 mL, and a few drops of dil. HCl were
added; to this solution, equimolar amount of ligand 2.19
m M ,i . e .0 . 4 8g ,0 . 5 2g ,0 . 6 9g ,a n d0 . 6 2g ,r e s p e c t i v e l y ,
for I-IV dissolved in ethanol (20 mL). The mixture was
stirred at room temperature for 15 min, for adjustment
of pH, and one drop of ammonia was added which
resulted in the formation of a precipitate. The precipi-
tate was filtered and washed with warm 70% ethanol
and recrystallized from water.
Synthesis of V
Yield: 58%. C10H7ClNO5Sb: Calcd. (%): C 31.74, H 1.86,
N 3.70, Sb 32.18; Found (%): C 31.21, H 1.45, N 3.39, Sb
31.80. FAB-MS (m/z) 377, 379 (M + 2). IR ν 3231 (N-
H), 1655 (C-N), 1561 (CO2)as, 1320 (CO2)s, Δν (CO2):
241, 450 (N ® Sb), 574 (O-Sb) cm
-1.
1H NMR (DMSO-
d6, 300 MHz) 8.24 (s, NH), 7.11-7.61 (m, Ar), 3.87 (s,
CH2).
13C NMR (DMSO-d6, 75 MHz) 177.4 (CONH),
174.7 (COO), 170.2 (COO), 107-138 (Ar), 40.2 (CH2).
Synthesis of VI
Yield: 58%. C11H9ClNO5Sb: Calcd. (%): C 33.67, H 2.31,
N 3.57, Sb: 31.03; Found (%): C 33.28, H 2.08, N 3.19,
Sb: 30.67. FAB-MS (m/z) 391, 393 (M + 2). IR ν 3265
(N-H), 1643 (C-N), 1551 (CO2)as, 1302 (CO2)s, Δν
(CO2): 249, 442 (N ® Sb), 582 (O-Sb) cm
-1.
1HN M R
(DMSO-d6, 300 MHz) 12.7 (s, COOH), 12.5 (s, COOH),
8.39 (s, NH), 7.07-7.59, (m, Ar) 3.51 (t, CH2 J:3 . 4 2 ) ,
2.33 (t, CH2 J:4 . 1 ) .
13C NMR (DMSO-d6, 75 MHz)
181.4 (CONH), 170.0 (COO), 160.1 (COO), 122-142
(Ar), 33.3 (CH2NH), 27.1 (CH2).
Synthesis of VII
Yield: 51%. C17H13ClNO5Sb: Calcd. (%): C 43.58, H 2.80,
N 2.99, Sb 25.99; Found (%): C 43.20, H 2.50, N 2.67, Sb
25.34. FAB-MS (m/z) 467, 469 (M + 2). IR ν 3276 (N-
H), 1666 (C-N), 1540 (CO2)as, 1311 (CO2)s, Δν (CO2):
229, 425 (N ® Sb), 580 (O-Sb) cm
-1.
1H NMR (DMSO-
d6, 300 MHz) 8.24 (s, NH), 7.10-8.1 (m, Ar), 5.06 (t,
CH, J: 9.7), 3.42 (d, CH2, J:9 . 3 ) .
13CN M R( D M S O - d 6 ,
75 MHz) 180.6 (CONH), 174.0 (COO), 169.5 (COO),
125-136 (Ar), 66.8 (CH), 30.6 (CH2).
Synthesis of VIII
Yield: 58%. C15H9ClNO5Sb: Calcd.(%): C 40.90, H 2.06,
N 3.18, Sb 27.64; Found (%):C 40.71, H 1.89, N 2.91, Sb
27.22. FAB-MS (m/z) 439, 441 (M + 2). IR ν 3266 (N-
H), 1678 (C-N), 1541 (CO2)as, 1336 (CO2)s, Δν (CO2):
137, 446 (N ® Sb), 568 (O-Sb) cm
-1.
1H NMR (DMSO-
d6, 300 MHz) 8.16 (s, NH), 7.06-8.55 (m, Ar).
13C NMR
(DMSO-d6, 75 MHz) 183.2 (CONH), 170.4 (COO),
172.8 (COO), 123-137 (Ar).
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Page 2 of 7Anti-leishmanial activity
Anti-leishmanial activity of the compound was carried
out on the pre-established cultures of L. major
(JISH118), L. major (MHOM/PK/88/DESTO), L. tro-
pica (K27), L. infantum (LEM3437), L. mex mex (LV4)
and L. donovani (H43). Parasites were cultured in
medium M199 with 10% foetal bovine serum; 25 mM
of HEPES, and 0.22 μg of penicillin and streptomycin,
respectively at 24°C in an incubator. 1 mg of each test
compound (I-VIII) was dissolved in 1 mL of water,
ethanol, methanol and DMSO according to their solu-
bilities. 1 mg of Amphotercin B was also dissolved in 1
mL of DMSO as reference drug. Parasites at log phase
were centrifuged at 3000 rpm for 3 min. Parasites were
diluted in fresh culture medium to a final density of 2
×1 0
6 cells/mL. In 96-well plates, 180 μLo fm e d i u m
was added in different wells. 20 μL of the extracts was
added in medium and serially diluted. 100 μLo fp a r a -
site culture was added in all the wells. Four rows left
for negative and positive controls: water, ethanol,
methanol and DMSO, respectively, serially diluted in
medium whereas positive control contained varying
concentrations of standard antileishmanial compound,
i.e. AmphotericinB. The plates were incubated for 72 h
at 24°C. Results were analyzed through dose versus
response by using nonlinear regression curve fit with
Graphad Prims5.
Anti-fungal activity
Agar tube dilution method was used for screening anti-
fungal activities against Aspergillus Flavus, Aspergillus
Fumigants, Aspergillus Niger,a n dFusarium Solani.A
sample of Media supplemented with DMSO and refer-
ence antifungal drugs was used as negative and positive
control, respectively. Tubes were then incubated at 27°C
for 4-7 days and examined twice weekly during incuba-
tion. Standard drug, Miconazole, used for the above sta-
ted fungi, growth in media containing sample under test
were determined by linear growth (mm) measuring, and
percent inhibition of growth was calculated with refer-
ence to negative control using formula.
Results and discussion
Ligands 2-{[(carboxymethyl)amino]carbonyl}benzoic acid
(I), 2-{[(2-carboxyethyl)amino]carbonyl}benzoic acid (II),
2-{[(1-carboxy-2-phenylethyl)amino]carbonyl}benzoic
acid (III), and 2-[(4-carboxyanilino)carbonyl]benzoic
acid (IV), and the complexes (V-VIII), all of which were
synthesized using a general procedure as shown in Fig-
ure 1. Analytic data for the complexes confirmed the
equimolar stoichiometries thereby tridentate ligation
(ONO) of I-IV towards Sb
III centre.
FTIR spectra
Solid-state FTIR spectra were recorded in the spectral
range of 4000-400 cm
-1, and important vibrational fre-
quencies were observed in this range. In the spectra of
ligands (I-IV), characteristic broad band of carboxylic
COOH functionality was observed in the range of 2800-
3000 cm
-1; OC-NH bond vibrated at 2600 cm
-1;a n d
aromatic C=C at 1500 cm
-1 [16]. Broad band observed
for carboxylic group disappeared in the spectra of com-
plexes indicating deprotonation of ligand. In the spectra
of compounds V-VIII, appearance of new band of med-
ium intensity around 430 cm
-1 indicated the coordina-
tion from N to antimony (O=C-NH ® Sb) in
pseudotrigonal bipyramidal arrangement (Figure 1) [17].
All the other bonds appeared at the same positions as in
the spectra of the ligands ruling out coordination from
carbonyl of phthalimido groups (Figure 1).
Solution-state multinuclear NMR spectra
In the solution-state
1Ha n d
13CN M Rs p e c t r ao fc o m -
pounds (V-VIII), all the nuclei resonated at appropriate
positions; in
1H NMR spectra, the disappearance of car-
boxylic protons confirmed deprotonation as observed in
the FTIR spectra of ligands (I-IV). In addition, down-
field shift of imine proton proved the coordinate linkage
of imine group toward antimony center (-NH ® Sb)
[18]. Similarly, in
13C NMR spectra, carbonyl (C=O)
adjacent to imine group resonated at downfield position
compared with that of the ligands confirming coordina-
tion linakge of imine with antimony center; all these
facts proved the 1:1 ligand to metal stoichiometry in
pseudotrigonal bipyramidal geometry (Figure 1) [19-21].
Further, either of the carboxylic groups displayed differ-
ent chemical shifts with carboxylic group attached to
phenyl ring appeared slightly at high filed.
MS & TGA analysis
In the FAB MS spectra of complexes VI-VIII, base peak
was observed at 245 m/z due to [O=C-O-(SbCl)-O-
C=O]
+ fragment. Molecular ion peaks of very low inten-
sity were observed with M + 2 peaks for isotopic
123Sb
were also seen. Based on the data obtained, fragmenta-
tion patterns for ligands I-IV (Figure 2a) and complexes
V-VIII (Figure 2b) have been proposed [20]. During the
TGA analyses, heating rates were suitably controlled at
10°C/min under a nitrogen atmosphere, and the weight
loss was measured ranging from ambient temperature
up to 700°C. The weight losses for all the complexes
were calculated for the corresponding temperature
ranges and are shown in Table 1. The metal percentages
left as metal oxide residues were compared with those
Khan et al. Organic and Medicinal Chemistry Letters 2011, 1:2
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Page 3 of 7Figure 1 Synthesis (I-VIII) and pseudotrigonal bipyramidal geometry.
Figure 2 MS fragmentation patterns.
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Page 4 of 7Table 2 In vitro Anti-leishmanial effect (IC50 in μg/mL) of I-VIII and standard drug (AmphotericinB)
Leishmanial strain Compound
I II III IV V VI VII VIII AmphotericinB
L. major 0.26 0.28 0.38 0.24 0.24 0.25 0.29 0.17 0.19
L. major (Pak) 0.33 0.32 0.30 0.31 0.24 0.33 0.22 0.11 0.22
L. tropica 0.22 0.39 0.25 0.23 0.24 0.35 0.28 0.18 0.25
L. mex mex 0.29 0.32 0.27 0.40 0.24 0.31 0.28 0.13 0.18
L. donovani 0.39 0.31 0.32 0.20 0.24 0.29 0.33 0.10 0.20
Table 1 Thermal analysis data of complexes V-VIII
Loss of Cl Oxide formation % Metal
Formula Temp. range (°C) Calculated Found Decomposition stage (°C) Temperature (°C) % Residue Calculated Found
C10H7ClNO5Sb 180-214 9.6 9.3 296-530 530 35 32.2 31.8
C11H9ClNO5Sb 178-207 9.2 8.8 300-485 485 66 31.0 30.7
C17H13ClNO5Sb 171-211 8.4 8.2 280-500 500 72 26.0 25.4
C15H9ClNO5Sb 182-220 8.9 8.5 308-550 550 70 27.6 26.3
Table 3 In vitro Anti-fungal Effect of I-VIII and Standard Drug (Miconazole)
Fungi Compound
I II III IV V VI VII VIII Miconazole
Aspergillus
flavus
+ ++ ++ ++ + ++ ++ ++++ +++
Aspergillus
Fumigants
++ ++ + +++ ++ ++ +++ ++++ +++
Aspergillus
Niger
++ + + ++ ++ + +++ ++++ ++++
Fusarium
Solani
+++ ++ ++ + ++ +++ ++ ++++ +++
Key: +: No activity, ++: Low activity, +++: moderate activity, ++++: significant activity
Figure 3 In vitro anti-leishmanial activity.
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Page 5 of 7determined by analytic metal content determination.
Complexes V-VIII exhibited a three-stage decomposi-
tion pattern; as a first step, beginning of the weight loss
occurred at 180, 178, 171, and 182 C, respectively,
because of the escape of one C1 atom; next step of
decomposition started at 280°C and extended up to 545°
C corresponding to the loss of rest of the ligand’sc o m -
ponents and formation of metal oxide [22].
All attempts employing different sets of conditions to
obtain single crystals of the synthesized complexes suita-
ble for XRD failed.
Anti-leishmanial and anti-fungal activities
All the compounds I-VIII were tested in vitro for their
bioavailabilities against five leishmanial strains, i.e., L.
major (JISH118), L. major (MHOM/PK/88/DESTO), L.
tropica (K27), L. infantum (LEM3437), L. mex mex
(LV4), and L. donovani (H43); and four fungi, viz.,
Aspergillus Flavus, Aspergillus Fumigants, Aspergillus
Niger,a n dFusarium Solani with one reference drug
Amphotericin B, and the results are given in Tables 2
and 3, respectively. In general all the complexes (V-
VIII) showed weaker activity compared to ligands (I-IV)
and the reference drugs, but the complex VIII showed
significant activity comparable to reference drugs. The
activities (IC50) of all the compounds I-VIII together
with AmphotericinB have been pictorially presented in
F i g u r e3 ,a n di ti se v i d e n tf r o mt h ep l o tt h a tt h ec o m -
pound VIII exhibited significant activity. In complex
VIII, the presence of bulkier R group, i.e., one benzyl
moiety may be responsible for enhancement in drug
uptake, thereby resulting significant activity [23,24].
Conclusions
Antimony
III center in all the synthesized complexes is
pseudotrigonal bipyramidal. Complex containing benzyl
group displays noteworthy anti-leishmanial and anti-fun-
gal effects. Proper understanding of exact relationship
between structure and activity needs further research.
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